Literature DB >> 8651838

Three-year follow-up of participants in a commercial weight loss program. Can you keep it off?

F Grodstein1, R Levine, L Troy, T Spencer, G A Colditz, M J Stampfer.   

Abstract

BACKGROUND: One third of Americans are obese, according to the 1988-1991 National Health and Nutrition Endpoint Survey III survey. Obesity increases the risk of death and a variety of chronic diseases. Numerous commercial weight loss programs demonstrate short-term success.
OBJECTIVE: To assess maintenance of weight loss achieved during dieting.
METHODS: We surveyed 192 participants in the Sandoz Nutrition (Sandoz Pharmaceuticals, Minneapolis, Minn) diet program approximately 3 years after participation. Initial date were supplied by the diet clinics and follow-up data, including weight at various points after the program, participation in other weight loss programs, and lifestyle variables, such as exercise, smoking, and television watching, were collected by a mailed questionnaire.
RESULTS: On average, the group lost 22 kg during the diet program. After the follow-up period, the mean weight (mean, 102.6 kg) was only modestly less than the group's original weight at the start of the diet (mean, 105.9 kg). Twelve percent of the subjects maintained 75% of their weight loss after leaving the diet program, 57% maintained at least 5% of the loss, and 40% gained back more than they had lost during the diet. The frequency of exercise after the diet program was the strongest predictor of weight loss maintenance, while television viewing predicted a gain in weight.
CONCLUSION: Given the apparent lack of substantial, long-term success at weight reduction, perhaps greater emphasis should be placed on prevention of obesity.

Entities:  

Mesh:

Year:  1996        PMID: 8651838

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  19 in total

1.  Weight loss counseling by health care providers.

Authors:  H Nawaz; M L Adams; D L Katz
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

2.  Isotemporal substitution paradigm for physical activity epidemiology and weight change.

Authors:  Rania A Mekary; Walter C Willett; Frank B Hu; Eric L Ding
Journal:  Am J Epidemiol       Date:  2009-07-07       Impact factor: 4.897

Review 3.  Lateral hypothalamic area neuropeptides modulate ventral tegmental area dopamine neurons and feeding.

Authors:  Patricia Perez-Bonilla; Krystal Santiago-Colon; Gina M Leinninger
Journal:  Physiol Behav       Date:  2020-05-31

4.  Effects of systemic or nucleus accumbens-directed dopamine D1 receptor antagonism on sucrose seeking in rats.

Authors:  Jeffrey W Grimm; John H Harkness; Christine Ratliff; Jesse Barnes; Kindsey North; Stefan Collins
Journal:  Psychopharmacology (Berl)       Date:  2011-02-12       Impact factor: 4.530

5.  Systemic injection of the DAD1 antagonist SCH 23390 reduces saccharin seeking in rats.

Authors:  Kenjiro Aoyama; Jesse Barnes; Jon Koerber; Edwin Glueck; Kylan Dorsey; Laura Eaton; Jeffrey W Grimm
Journal:  Appetite       Date:  2016-05-11       Impact factor: 3.868

6.  Five-year outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in a comprehensive bariatric surgery program in Canada.

Authors:  Nicolas Christou; Evangelos Efthimiou
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

7.  Impact of obesity and bariatric surgery on survival.

Authors:  Nicolas V Christou
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

8.  Analysis of the factors affecting the success of weight reduction programs.

Authors:  Jungsun Kim; Sue Kyung Park; Yun Jeong Lim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

9.  Bariatric surgery waiting times in Canada.

Authors:  Nicolas V Christou; Evangelos Efthimiou
Journal:  Can J Surg       Date:  2009-06       Impact factor: 2.089

Review 10.  Reproductive implications of bariatric surgery: pre- and postoperative considerations for extremely obese women of childbearing age.

Authors:  Ellen J Landsberger; Edith D Gurewitsch
Journal:  Curr Diab Rep       Date:  2007-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.